Article Dans Une Revue Arthritis & rheumatology Année : 2023

The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria

Medha Barbhaiya (1) , Stephane Zuily (2, 3) , Ray Naden (4) , Alison Hendry (5) , Florian Manneville (6) , Mary‐carmen Amigo (7) , Zahir Amoura (8, 9) , Danieli Andrade (10) , Laura Andreoli (11, 12) , Bahar Artim-Esen (13) , Tatsuya Atsumi (14) , Tadej Avcin (15, 16) , H. Michael Belmont (17) , Maria Laura Bertolaccini (18) , D. Ware Branch (19) , Graziela Carvalheiras (20) , Alessandro Casini (21) , Ricard Cervera (22, 23) , Hannah Cohen (24) , Nathalie Costedoat-Chalumeau (25, 26) , Mark Crowther (27) , Guilherme de Jesus (28) , Aurélien Delluc (29, 30) , Sheetal Desai (31) , Maria de Sancho (1) , Katrien M.J. Devreese (32, 33) , Reyhan Diz-Kucukkaya (13) , Ali Duarte-Garcia (34) , Camille Frances (35) , David Garcia (36) , Jean-Christophe Gris (37, 38) , Natasha Jordan (39) , Rebecca Leaf (40) , Nina Kello (41) , Jason Knight (42) , Carl Laskin (43) , Alfred I. Lee (44) , Kimberly Legault (27) , Steve Levine (45, 46) , Roger Levy (47, 48) , Maarten Limper (49, 50) , Michael Lockshin (1) , Karoline Mayer-Pickel (51) , Jack Musial (52) , Pier Luigi Meroni (53) , Giovanni Orsolini (54) , Thomas Ortel (55) , Vittorio Pengo (56) , Michelle Petri (57) , Guillermo Pons-Estel (58) , Jose Gomez-Puerta (22, 59) , Quentin Raimboug (60) , Robert Roubey (61) , Giovanni Sanna (62) , Surya Seshan (1) , Savino Sciascia (63, 64) , Maria Tektonidou (65) , Angela Tincani (11, 12) , Denis Wahl (2, 3) , Rohan Willis (66) , Cecile Yelnik (67) , Catherine Zuily (2, 68) , Francis Guillemin (6) , Karen Costenbader (69) , Doruk Erkan (1)
1 Weill Cornell Medicine [Cornell University]
2 DCAC - Défaillance Cardiovasculaire Aiguë et Chronique
3 Centre régional de compétence des Maladies systémiques et auto-immunes rares de l'adulte et Maladies vasculaires rares
4 Auckland City Hospital
5 Middlemore Hospital
6 CIC-EC - Centre d'investigation clinique - Epidémiologie clinique [Nancy]
7 ABC Hospital - Centro Médico ABC [Mexico] = ABC Medical Center [Mexico]
8 CHU Pitié-Salpêtrière [AP-HP]
9 CIMI - Centre d'Immunologie et des Maladies Infectieuses
10 USP - Universidade de São Paulo = University of São Paulo
11 ASST Spedali Civili di Brescia - Azienda Socio Sanitaria Territoriale Spedali Civili di Brescia [Brescia]
12 UniBs - Università degli Studi di Brescia = University of Brescia
13 Istanbul University
14 Hokkaido University [Sapporo, Japan]
15 UMCL - University Medical Centre Ljubljana
16 University of Ljubljana
17 NYU - New York University [New York]
18 King‘s College London
19 University of Utah
20 Centro Hospitalar do Porto
21 UNIGE - Université de Genève = University of Geneva
22 Clinic Barcelona Hospital Universitari
23 UB - Universitat de Barcelona
24 UCL - University College London [UCL]
25 CRMR - Centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares de l'adulte d'Île de France, Est et Ouest / Reference center for rare systemic autoimmune and autoinflammatory diseases in adults in Île-de-France, East and West
26 CRESS (U1153 / UMR_A 1125) - Centre for Research in Epidemiology and Statistics | Centre de Recherche Épidémiologie et Statistiques
27 McMaster University [Hamilton, Ontario]
28 UERJ - Universidade do Estado do Rio de Janeiro [Brasil] = Rio de Janeiro State University [Brazil] = Université d'État de Rio de Janeiro [Brésil]
29 OHRI - Ottawa Hospital Research Institute [Ottawa]
30 University of Ottawa [Ottawa]
31 UC Irvine - University of California [Irvine]
32 Ghent University Hospital
33 UGent - Universiteit Gent = Ghent University = Université de Gand
34 Mayo Clinic [Rochester]
35 CHU Tenon [AP-HP]
36 University of Washington [Seattle]
37 IDESP - Institut Desbrest d'Epidémiologie et de Santé Publique
38 CHU Nîmes - Centre Hospitalier Universitaire de Nîmes
39 Addenbrooke's Hospital
40 Massachusetts General Hospital [Boston]
41 North Shore-LIJ - Northwell Health [North Shore-Long Island Jewish Health System / North Shore-LIJ Health System]
42 UMich - Université du Michigan = University of Michigan [Ann Arbor]
43 University of Toronto
44 YSM - Yale School of Medicine [New Haven, Connecticut]
45 SUNY Downstate Medical Center
46 Maimonides Medical Center
47 UNIRIO - Universidade Federal do Estado do Rio de Janeiro
48 GlaxoSmithKline
49 UMCU - University Medical Center [Utrecht]
50 Universiteit Utrecht / Utrecht University [Utrecht]
51 Medical University of Graz = Medizinische Universität Graz
52 JUMC - Jagiellonian University - Medical College
53 IAI - Istituto Auxologico Italiano IRCCS Ospedale San Luca [Milan, Italy]
54 Azienda Ospedaliera Universitaria Integrata of Verona
55 Duke University Medical Center
56 AOUP - Azienda Ospedale Università di Padova = Hospital-University of Padua
57 Johns Hopkins University School of Medicine [Baltimore]
58 GO-Crear - Centro Regional de Enfermedades Autoinmunes y Reumáticas de Grupo Oroño
59 IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer
60 AP-HP - Hôpital Bichat - Claude Bernard [Paris]
61 UNC-Chapel Hill - Université de Caroline du Nord à Chapel Hill = University of North Carolina [Chapel Hill]
62 Guy's and St Thomas' NHS Foundation Trust
63 UNITO - Università degli studi di Torino = University of Turin
64 OSGB - Ospedale San Giovanni Bosco [Turin, Italy]
65 NKUA - National and Kapodistrian University of Athens
66 UTMB - The University of Texas Medical Branch
67 RID-AGE - Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167
68 Service d'Obstétrique et de Gynécologie [CHRU Nancy]
69 BWH - Brigham & Women’s Hospital [Boston]
Medha Barbhaiya
Ali Duarte-Garcia
Camille Frances
  • Fonction : Auteur
  • PersonId : 941936

Résumé

Objective To develop new antiphospholipid syndrome (APS) classification criteria with high specificity for use in observational studies and trials, jointly supported by the American College of Rheumatology (ACR) and EULAR. Methods This international multidisciplinary initiative included 4 phases: 1) Phase I, criteria generation by surveys and literature review; 2) Phase II, criteria reduction by modified Delphi and nominal group technique exercises; 3) Phase III, criteria definition, further reduction with the guidance of real‐world patient scenarios, and weighting via consensus‐based multicriteria decision analysis, and threshold identification; and 4) Phase IV, validation using independent adjudicators’ consensus as the gold standard. Results The 2023 ACR/EULAR APS classification criteria include an entry criterion of at least one positive antiphospholipid antibody (aPL) test within 3 years of identification of an aPL‐associated clinical criterion, followed by additive weighted criteria (score range 1–7 points each) clustered into 6 clinical domains (macrovascular venous thromboembolism, macrovascular arterial thrombosis, microvascular, obstetric, cardiac valve, and hematologic) and 2 laboratory domains (lupus anticoagulant functional coagulation assays, and solid‐phase enzyme‐linked immunosorbent assays for IgG/IgM anticardiolipin and/or IgG/IgM anti–β 2 ‐glycoprotein I antibodies). Patients accumulating at least 3 points each from the clinical and laboratory domains are classified as having APS. In the validation cohort, the new APS criteria versus the 2006 revised Sapporo classification criteria had a specificity of 99% versu s 86%, and a sensitivity of 84% versus 99%. Conclusion These new ACR/EULAR APS classification criteria were developed using rigorous methodology with multidisciplinary international input. Hierarchically clustered, weighted, and risk‐stratified criteria reflect the current thinking about APS, providing high specificity and a strong foundation for future APS research.

HAL

Est identique à hal-04583619 Article Medha Barbhaiya, Stephane Zuily, Ray Naden, Alison Hendry, Florian Manneville, et al.. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Annals of the Rheumatic Diseases, 2023, 82 (10), pp.1258-1270. ⟨10.1136/ard-2023-224609⟩. ⟨hal-04583619⟩

Article publié simultanément dans deux revues

Dates et versions

hal-04399122 , version 1 (17-01-2024)

Identifiants

Citer

Medha Barbhaiya, Stephane Zuily, Ray Naden, Alison Hendry, Florian Manneville, et al.. The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis & rheumatology, 2023, 75 (10), pp.1687-1702. ⟨10.1002/art.42624⟩. ⟨hal-04399122⟩
327 Consultations
0 Téléchargements

Altmetric

Partager

  • More